Sağlık Uzmanları AI Denetimi ve İnovasyonunu Tartışıyor
At the recent Boston Consulting Group event held in San Francisco during the JPM Healthcare Conference, experts gathered to discuss the evolving landscape of AI technology in healthcare and the critical role of government oversight. The panelists delved into the pressing issue of how the changing administration will impact the advancement of AI technology in the healthcare sector.
Micky Tripathi: Değişen Sağlık Sektöründe AI ve Denetimin Önemi
Micky Tripathi, assistant secretary for technology policy, national coordinator for health IT, and chief AI officer for the U.S. Department of Health and Human Services (HHS), emphasized the decade-long journey of health information technology in the United States. Tripathi highlighted the transformative impact of programs like the Meaningful Use program and the HITECH Act in driving the adoption of electronic health records (EHRs) across hospitals and physician offices.
Tripathi underscored the significance of AI in healthcare while stressing the crucial need for oversight to ensure patient safety and data security. He elaborated on the recent release of HHS’s AI Strategic Plan, outlining key recommendations for research, drug development, and medical product safety. Tripathi also discussed the Biden administration’s regulations on AI use in healthcare, emphasizing transparency and accountability.
Ashkan Afkhami: Federal Hükümet ve Sektör Arasındaki İşbirliğinin Önemi
As the panel’s moderator, Ashkan Afkhami, BCG’s managing director, emphasized the collaborative efforts between the federal government and the healthcare industry in advancing AI technology. Afkhami highlighted the importance of continued co-creation regardless of the administration in power, emphasizing the need for sustained innovation and partnership.
Tripathi expressed cautious optimism about the incoming administration, noting the inherent uncertainty during the transition period. He emphasized the need for strategic decision-making and prioritization in navigating the complexities of healthcare regulations and statutory requirements.
Sara Vaezy: AI Denetimi ve Standartların Önemi
Sara Vaezy, executive vice president at Providence, stressed the critical role of monitoring AI technologies to ensure ethical use and compliance. She advocated for the establishment of open standards in AI to promote transparency and interoperability across different healthcare systems. Vaezy highlighted the potential of open standards to unlock innovation and overcome the constraints posed by legacy providers.
The discussions at the BCG event underscored the complex interplay between AI innovation, government oversight, and industry collaboration in shaping the future of healthcare. As stakeholders navigate the evolving landscape of healthcare technology, the emphasis remains on responsible AI deployment, regulatory compliance, and strategic partnerships to drive meaningful change in the healthcare industry.